206 related articles for article (PubMed ID: 29876954)
1. A noniterative sample size procedure for tests based on t distributions.
Tang Y
Stat Med; 2018 Sep; 37(22):3197-3213. PubMed ID: 29876954
[TBL] [Abstract][Full Text] [Related]
2. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
Vickers AJ
BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
[TBL] [Abstract][Full Text] [Related]
3. A U-statistics based approach to sample size planning of two-arm trials with discrete outcome criterion aiming to establish either superiority or noninferiority.
Wellek S
Stat Med; 2017 Feb; 36(5):799-812. PubMed ID: 27878839
[TBL] [Abstract][Full Text] [Related]
4. Closed-form REML estimators and sample size determination for mixed effects models for repeated measures under monotone missingness.
Tang Y
Stat Med; 2017 Jun; 36(13):2135-2147. PubMed ID: 28226391
[TBL] [Abstract][Full Text] [Related]
5. A simple sample size formula for analysis of covariance in randomized clinical trials.
Borm GF; Fransen J; Lemmens WA
J Clin Epidemiol; 2007 Dec; 60(12):1234-8. PubMed ID: 17998077
[TBL] [Abstract][Full Text] [Related]
6. Power and Sample Size Calculations for Contrast Analysis in ANCOVA.
Shieh G
Multivariate Behav Res; 2017; 52(1):1-11. PubMed ID: 28121163
[TBL] [Abstract][Full Text] [Related]
7. Sample size for comparing negative binomial rates in noninferiority and equivalence trials with unequal follow-up times.
Tang Y
J Biopharm Stat; 2018; 28(3):475-491. PubMed ID: 28541744
[TBL] [Abstract][Full Text] [Related]
8. Power Analysis and Sample Size Planning in ANCOVA Designs.
Shieh G
Psychometrika; 2020 Mar; 85(1):101-120. PubMed ID: 31823115
[TBL] [Abstract][Full Text] [Related]
9. Sample size planning for the noninferiority or equivalence of a linear contrast with cost considerations.
Luh WM; Guo JH
Psychol Methods; 2016 Mar; 21(1):13-34. PubMed ID: 26121080
[TBL] [Abstract][Full Text] [Related]
10. A unified approach to power and sample size determination for log-rank tests under proportional and nonproportional hazards.
Tang Y
Stat Methods Med Res; 2021 May; 30(5):1211-1234. PubMed ID: 33819109
[TBL] [Abstract][Full Text] [Related]
11. Effect of heteroscedasticity between treatment groups on mixed-effects models for repeated measures.
Gosho M; Maruo K
Pharm Stat; 2018 Sep; 17(5):578-592. PubMed ID: 29978944
[TBL] [Abstract][Full Text] [Related]
12. Sample size determination for equivalence assessment with multiple endpoints.
Sun A; Dong X; Tsong Y
J Biopharm Stat; 2014; 24(6):1203-14. PubMed ID: 25032845
[TBL] [Abstract][Full Text] [Related]
13. Sample size determination for a three-arm equivalence trial of normally distributed responses.
Chang YW; Tsong Y; Dong X; Zhao Z
J Biopharm Stat; 2014; 24(6):1190-202. PubMed ID: 25098678
[TBL] [Abstract][Full Text] [Related]
14. Sample size determination for a three-arm equivalence trial of Poisson and negative binomial responses.
Chang YW; Tsong Y; Zhao Z
J Biopharm Stat; 2017; 27(2):239-256. PubMed ID: 27936355
[TBL] [Abstract][Full Text] [Related]
15. Sample size calculation for the Andersen-Gill model comparing rates of recurrent events.
Tang Y; Fitzpatrick R
Stat Med; 2019 Oct; 38(24):4819-4827. PubMed ID: 31397911
[TBL] [Abstract][Full Text] [Related]
16. Unconditional exact tests for equivalence or noninferiority for paired binary endpoints.
Hsueh HM; Liu JP; Chen JJ
Biometrics; 2001 Jun; 57(2):478-83. PubMed ID: 11414572
[TBL] [Abstract][Full Text] [Related]
17. Wald tests for variance-adjusted equivalence assessment with normal endpoints.
Chen YM; Weng YT; Dong X; Tsong Y
J Biopharm Stat; 2017; 27(2):308-316. PubMed ID: 27906607
[TBL] [Abstract][Full Text] [Related]
18. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD; Peduzzi PN
Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
[TBL] [Abstract][Full Text] [Related]
19. Exact calculation of power and sample size in bioequivalence studies using two one-sided tests.
Shen M; Russek-Cohen E; Slud EV
Pharm Stat; 2015; 14(2):95-101. PubMed ID: 25477145
[TBL] [Abstract][Full Text] [Related]
20. Generalized F test and generalized deviance test in two-way ANOVA models for randomized trials.
Shen J; He X
J Biopharm Stat; 2014; 24(3):523-34. PubMed ID: 24697334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
